Behind the Scenes of Amgen's Latest Options Trends
Options trading presents higher risks and potential rewards. Astute traders manage these risks by continually educating ...
Akari Therapeutics Appoints Biotechnology Industry Leader, Abizer Gaslightwala, as President and Chief Executive Officer
Former SVP and Franchise Head for US Oncology at Jazz Pharmaceuticals, with established track record for leading a portfolio of products spanning ...
Akari Therapeutics Plc: Akari Therapeutics Appoints Biotechnology Industry Leader, Abizer Gaslightwala, as President and Chief Executive Officer
Former SVP and Franchise Head for US Oncology at Jazz Pharmaceuticals, with established track record for leading a portfolio ...
Contract Pharma17h
Akari Therapeutics Appoints Abizer Gaslightwala President and CEO
Gaslightwala is a former SVP for US Oncology at Jazz and held several leadership roles at Amgen, Pfizer, and Johnson & Johnson.
24/7 Wall St. on MSN19h
2025’s Five Highest Yielding Dogs of the Dow Could Explode Higher
The ‘Dogs of the Dow’ is a well-known strategy first published in 1991 by Michael Higgins. The plan seeks to maximize the ...
FierceBiotech22h
Fierce Biotech Layoff Tracker 2025: Elevation eliminates 70% of staff; bit.bio cuts 25% of workforce
Release Jan. 7 - CytomX Therapeutics: The California biotech is shrinking its head count by 40% and reassessing the future of Amgen-partnered T-cell engager CX-904 as a way to save cash and focus ...